News

Filter

Current filters:

PricingEurope

1 to 9 of 26 results

Pharma pricing regulation puts Spain 15% lower than Eurozone average

Pharma pricing regulation puts Spain 15% lower than Eurozone average

16-02-2015

The average price per standard unit of medicine in Spain was 15% lower than the average of Eurozone countries…

EuropePharmaceuticalPharmaceutical industryPricingSpain

Access to Medicine Foundation launches its 2014 report at European Parliament

Access to Medicine Foundation launches its 2014 report at European Parliament

16-02-2015

The 2014 Access to Medicine Foundation presented its 2014 report at the European Parliament, showing…

Business FinanceEFPIAEuropePharmaceuticalPricing

Médecins du Monde challenges Gilead’s Sovaldi patent in EU

Médecins du Monde challenges Gilead’s Sovaldi patent in EU

11-02-2015

The high price of US biotech major Gilead Sciences’ blockbuster hepatitis C (HCV) drug Sovaldi (sofosbuvir)…

Anti-viralsEuropeGilead SciencesPharmaceuticalPricingSovaldi

Standardization of European HTA bodies is inevitable: EFPIA head

Standardization of European HTA bodies is inevitable: EFPIA head

09-01-2015

The director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA)…

EFPIAEuropeMarkets & MarketingPharmaceuticalPricingRegulation

Spain’s Supreme Court opines on Pfizer dual pricing contracts

Spain’s Supreme Court opines on Pfizer dual pricing contracts

15-12-2014

The Spanish Supreme Court has reviewed a ruling adopted by the Audiencia Nacional, itself annulling a…

EuropeLegalPfizerPharmaceuticalPricingSpain

Predictive biomarkers could help costly cancer drugs secure market access

25-11-2014

Biomarker driven prescribing is likely to positively influence perceptions of oncology drugs for both…

EuropeMarkets & MarketingOncologyPharmaceuticalPricing

Opportunity to promote good antibiotics prescription practices, says EGA

19-11-2014

The European Generic medicines Association (EGA) used the platform of European Antibiotic Awareness Day…

Antibiotics and Infectious diseasesEuropeGenericsMarkets & MarketingPricing

Incyte earns $60 million milestone on European reimbursement for Jakavi

Incyte earns $60 million milestone on European reimbursement for Jakavi

02-10-2014

US biopharma company Incyte says that it has earned a $60 million milestone payment from Swiss pharma…

BiotechnologyEuropeFinancialIncyteJakafiJakaviNovartisOncologyPricing

1 to 9 of 26 results

COMPANY SPOTLIGHT

Menarini

Back to top